Anniversary milestone for New Zealands only psoriasis patient support group. A revolutionary new treatment is now available on the NHS, offering hope to the 1. Patients will qualify for Stelara only if their psoriasis affects their quality of life and does not improve with standard treatments. But today, Callum is psoriasis free and it’s not new drugs or lotions that brought this about.
A new treatment could bring a smile to the faces of thousands who suffer from the skin disease psoriasis. Dr Shernaz Walton, a consultant dermatologist at the Princess Royal Hospital in Hull, says: ‘A lot of patients like Lindsey get psoriasis on the face or sensitive parts of the body where it is not advisable to use most of the current drugs. Dr Phil Alderson, medical associate director of the Centre for Clinical Practice at NICE, says: Greater responsibility for the condition within primary care could improve access to treatments and support for people with this highly visible and potentially stigmatising disease. Psoriasis Association Southland (PAS) – the only support group for people living with psoriasis in New Zealand – and drug company AbbVie, in conjunction with dermatologists, recently surveyed 492 New Zealanders living with psoriasis.
Achieved 10 new-to-brand prescription market share in the US. 2. GSK and Novartis will create a new world-leading Consumer Healthcare business with 2013 pro forma revenues of 6. Finally, and very importantly, this transaction strengthens GSK’s offering to patients and consumers. GSK is currently reviewing this portfolio to ensure the Group evaluates all options to maximise its value.